Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes.

The New Zealand medical journal

Volumn 113, Issue 1119, 2000, Pages 425-428

  Swinburn, B ^a   Milne, R J ^a   Richards, M ^a   Begg, E ^a   Foote, S ^a   Jackson, R ^a  

^a National Heart Foundation of New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMICS; EVIDENCE BASED MEDICINE; FEE; HEALTH INSURANCE; HUMAN; METHODOLOGY; NEW ZEALAND; ORGANIZATION; ORGANIZATION AND MANAGEMENT; REIMBURSEMENT; RISK ASSESSMENT;

CARDIOVASCULAR AGENTS; COST CONTROL; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; EVIDENCE-BASED MEDICINE; FEES, PHARMACEUTICAL; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; INSURANCE, PHARMACEUTICAL SERVICES; NEW ZEALAND; RATE SETTING AND REVIEW; RISK ASSESSMENT;

EID: 0034644521     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)